Pay in 4 interest-free payments of $5.33 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
In high-income nations with established diabetes care systems, GLP-1 receptor agonists exhibit advantageous cost-effectiveness ratios when accounting for cardiovascular and renal protective benefits, with incremental cost-effectiveness ratios generally falling below $50,000 per quality-adjusted life year (QALY) for high-risk patients (Kong et al
Top-up Grant from the PhD Programme in Health Sciences, University of Basel
We had a few documentation format preferences, and they adjusted quickly without delaying dispatch
Since 1963, we have empowered our millions of members to build healthy habits to live longer lives
US$ 28.50
US$ 27.73
US$ 20.56
US$ 22.20
![Melanoma Treatment (PDQ®): Treatment - Patient Information [NCI]](https://ixbapi.healthwise.net/Resource/14.9/en-us/media/medical/nci/cdr0000799465.jpg)
US$ 29.89
US$ 24.98
US$ 27.60
US$ 25.87
US$ 29.22
US$ 25.63
US$ 29.87
US$ 28.29
US$ 21.28
